BlackRock
MXCT icon

BlackRock’s MaxCyte MXCT Stock Holding History

BlackRock’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76M Sell
3,060,960
-5,737,513
-65% -$5.72M ﹤0.01% 4008
2026
Q1 		$6.18M Sell
8,798,473
-444,114
-5% -$415K ﹤0.01% 3745
2025
Q4 		$14.3M Sell
9,242,587
-741,326
-7% -$1.18M ﹤0.01% 3279
2025
Q3 		$15.8M Sell
9,983,913
-218,330
-2% -$379K ﹤0.01% 3231
2025
Q2 		$22.2M Buy
10,202,243
+2,033,867
+25% +$4.92M ﹤0.01% 2957
2025
Q1 		$22.3M Buy
8,168,376
+144,936
+2% +$571K ﹤0.01% 2865
2024
Q4 		$33.4M Sell
8,023,440
-464,667
-5% -$1.76M ﹤0.01% 2713
2024
Q3 		$33M Buy
8,488,107
+345,743
+4% +$1.46M ﹤0.01% 2723
2024
Q2 		$31.9M Buy
8,142,364
+912,791
+13% +$3.93M ﹤0.01% 2706
2024
Q1 		$30.3M Sell
7,229,573
-111,813
-2% -$525K ﹤0.01% 2753
2023
Q4 		$34.5M Buy
7,341,386
+453,390
+7% +$1.77M ﹤0.01% 2711
2023
Q3 		$21.5M Sell
6,887,996
-32,088
-0.5% -$129K ﹤0.01% 2903
2023
Q2 		$31.8M Sell
6,920,084
-100,577
-1% -$462K ﹤0.01% 2754
2023
Q1 		$34.8M Buy
7,020,661
+205,579
+3% +$1.01M ﹤0.01% 2679
2022
Q4 		$37.2M Buy
6,815,082
+367,139
+6% +$2.25M ﹤0.01% 2671
2022
Q3 		$41.9M Buy
6,447,943
+784,524
+14% +$4.38M ﹤0.01% 2577
2022
Q2 		$26.8M Buy
5,663,419
+219,582
+4% +$1.08M ﹤0.01% 2922
2022
Q1 		$38.1M Buy
5,443,837
+229,373
+4% +$1.57M ﹤0.01% 2741
2021
Q4 		$53.1M Buy
5,214,464
+4,535,552
+668% +$48.7M ﹤0.01% 2624
2021
Q3 		$8.29M Buy
+678,912
New +$10.2M ﹤0.01% 3756

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock's MXCT Position: Q2 2026 in Review

BlackRock reduced its MaxCyte (MXCT) stake by 65% in Q2 2026, selling an estimated $5.72M and leaving 3,060,960 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #4008.

BlackRock first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $53.1M in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • BlackRock held 3,060,960 shares of MaxCyte worth $3.76M as of Q2 2026.
  • BlackRock sold 5,737,513 MaxCyte shares in Q2 2026, an estimated $5.72M.
  • MaxCyte made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4008 holding.
  • BlackRock first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
  • BlackRock's MaxCyte position peaked at $53.1M in Q4 2021.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.